John F. Ginascol, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 9,858 shares at $77.58 ($769K) on 2020-03-02, disclosed to the SEC on 2020-03-03.
Open-market sale of $769k ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.19 | 2,246 | $178K | 23.1% |
| 2 | $77.58 | 5,600 | $434K | 56.5% |
| 3 | $77.89 | 1,006 | $78K | 10.2% |
| 4 | $77.89 | 1,006 | $78K | 10.2% |
| Total | $78.01 avg | 9,858 | $769K | 100% |
| Filing → |
| ABT | SELL | 2022-03-02 | $43K | — | Filing → |
| ABT | SELL | 2021-03-02 | $42K | — | Filing → |
| ABT | SELL | 2020-04-23 | $12.1M | — | Filing → |